Lowest Price Guaranteed From USD 5,899
Published
January 2023
Pages
175
View Count
2604
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
Smart labels market (pharmaceutical and healthcare labels), driven by over 09+ companies offering smart labels, is expected to grow at 15% CAGR in the coming decade.
The annual market for counterfeit drugs is estimated to be USD 200 billion and this value is believed to be expanding rapidly. As per a report published by the World Health Organization (WHO), 20% of counterfeit pharmaceuticals include an incorrect amount of the active ingredient, while 30% of the counterfeit drugs contain no active ingredient at all. Such illegal practices are likely to endanger the lives of the patients, as well as tarnish the developer company's reputation. In order to overcome the aforementioned concerns, label service providers have strengthened the ongoing labelling practices and are shifting towards smart labelling technologies. A smart label comprises of printed information, a bar code identifier and a small transponder. This transponder contains a processing chip and an antenna that allows physical objects to communicate with the tag reader (for instance, RFID reader). Smart labels offer several benefits, such as tracing and tracking products in a supply chain, and tamper proofing, discouraging counterfeit drugs packaging. In this context, it is worth mentioning that the smart labelling technology is expected to save USD 0.8 - 1.5 million per year per company, through their applications in inventory management. Despite numerous growth drivers for adopting smart label technologies, there are some factors that may hinder the immediate uptake of smart label technologies. These include high price of integrating the technology as well as lack of well-established regulatory standards across the globe. Such considerations may also prevent investment opportunities for smart label technologies. It is worth highlighting that, in the recent years, consortiums, such as GS1 standards and RAIN Alliance, have been established to standardize global regulations.
At present, various types of smart labels, including radio frequency identification device labels (RFID), internet of things (IoT) labels, bluetooth labels and others, are being deployed across various applications in the pharmaceutical and healthcare markets; these include supply chain management, asset tracking, patient tracking and clinical trial labelling. Currently, more than 90 companies are engaged in providing these labels for various applications. In addition, with an aim to diversify their area of application and enhance their existing product portfolios, players engaged in providing smart pharmaceutical and healthcare labels are actively collaborating with other industry stakeholders. It is also worth mentioning that over 400 patents related to smart labels have been filed / granted, highlighting the continuous pace of innovation in this field. Driven by the growing demand for authentic and efficient drugs and ongoing efforts of players to integrate sophisticated features in the product design and affiliated technology, the smart pharmaceutical and healthcare labels market is likely to witness noteworthy growth over the coming years.
Scope of the Report
The “Smart Labels Market (Pharmaceutical and Healthcare Labels) by Type of Technology (RFID, NFC and Other Technologies), Type of Packaging (Primary Packaging and Secondary Packaging), Type of Primary Packaging (Vials, Syringes, Cartridges, Ampoules, Bottles and Blister Packs), Type of Secondary Packaging (Boxes, Cartons and Pouches) and Key Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America) - Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of the current market landscape and future opportunities associated with the smart pharmaceutical and healthcare labels, offering in-depth analyses of the various business entities engaged in this domain, across different segments as defined in the below table:
| Report Attribute | Details | |
|
Forecast Period |
2022 – 2035 |
|
|
Type of Technology |
RFID, NFC, Others |
|
|
Type of Packaging |
Primary packaging, Secondary packaging | |
|
Type of Primary Packaging |
Vials, Syringes, Cartridges, Ampoules, Bottles, Blister Packs | |
|
Type of Secondary Packaging |
Boxes, Cartons, Pouches | |
| Key Geographical Regions | North America, Europe, Asia-Pacific, MENA, Latin America | |
Amongst other elements, the report includes:
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the smart pharmaceutical and healthcare labels market, over the coming years. We have provided informed estimates on the evolution of the market in the short to mid-term and mid to long term, for the period 2022-2035. Additionally, our year-wise projections of the current and future opportunity have been segmented based on relevant parameters, such as [A] type of technology (RFID Labels, NFC Labels and other Labels), [B] type of packaging (primary packaging and secondary packaging), [C] type of primary packaging (vials, syringes, cartridges, ampoules, bottles and blister packs), [D] type of secondary packaging (boxes, cartons and pouches) and [E] key geographical regions (North America, Europe, Asia Pacific, MENA and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines
2. EXECUTIVE SUMMARY
2.1 Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
3.2.1 Types of Smart Labels
3.2.1.1. Radio Frequency Identification Device (RFID)
3.2.1.2. Near-Field Communication (NFC)
3.2.1.3. Internet of Things (IoT)
3.2.2. Need for Smart Labels in the Healthcare Sector
3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Technology
4.2.6. Analysis by Company Size and Type of Technology
4.2.7. Analysis by Type of RFID Frequency Band
4.2.8. Analysis by Area(s) of Application
4.2.9. Analysis by Company Size and Area(s) of Application
4.2.10. Analysis by Type of Technology and Area(s) of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. CCL Industries
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Area(s) of Application
6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
6.3.1. Company Overview
6.3.2. Area(s) of Application
6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Area(s) of Application
6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
6.5.1. Company Overview
6.5.2. Area(s) of Application
6.5.3. Recent Developments and Future Outlook
6.6. SATO Asia Pacific
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Area(s) of Application
6.6.4. Recent Developments and Future Outlook
6.7. Invengo
6.7.1. Company Overview
6.7.2. Area(s) of Application
6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
6.8.1. Company Overview
6.8.2. Area(s) of Application
6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
6.9.1. Company Overview
6.9.2. Area(s) of Application
6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
6.10.1. Company Overview
6.10.2. Area(s) of Application
6.10.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Publication Year and Type of Patent
7.3.3. Analysis by CPC Code
7.3.4. Analysis by Type of Applicant
7.3.5. Analysis by Geography
7.3.6. Analysis by Emerging Focus Areas
7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Most Active Players: Analysis by Number of Partnerships
8.3.4. Regional Analysis
8.3.4.1. Local and International Agreements
8.3.4.2. Intercontinental and Intracontinental Agreements
9. BLUE OCEAN STRATEGY
9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
9.2.1 Red Ocean
9.2.2 Blue Ocean
9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
9.2.4.1. Value Innovation
9.2.4.2. Strategy Canvas
9.2.4.3. Four Action Framework
9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
9.2.4.5. Six Path Framework
9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
9.2.4.7. Three Tiers of Noncustomers
9.2.4.8. Sequence of Blue Ocean Strategy
9.2.4.9. Buyer Utility Map
9.2.4.10. The Price Corridor of the Mass
9.2.4.11. Four Hurdles to Strategy Execution
9.2.4.12. Tipping Point Leadership
9.2.4.13. Fair Process
9.3. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors
12. CONCLUDING REMARKS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Comparison of Radio Frequency Identification Device (RFID) and Near-Field Communication (NFC)
Figure 3.2 Advantages Offered by Smart Labels to Healthcare Industry
Figure 4.1 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Year of Establishment
Figure 4.2 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size
Figure 4.3 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Location of Headquarters
Figure 4.4 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology
Figure 4.6 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Type of Technology
Figure 4.7 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of RFID Frequency Band
Figure 4.8 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Area(s) of Application
Figure 4.9 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Area(s) of Application
Figure 4.10 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology and Area(s) of Application
Figure 5.1 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in North America
Figure 5.2 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in Europe
Figure 5.3 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific & RoW
Figure 6.1 CCL Industries: Annual Revenues, 2018 – H1 2022 (CAD Billion)
Figure 6.2 CCL Industries: Area(s) of Application
Figure 6.3 Schreiner: Area(s) of Application
Figure 6.4 Datalogic: Annual Revenues, 2018 – H1 2022 (EUR Billion)
Figure 6.5 Datalogic: Area(s) of Application
Figure 6.6 Tadbik: Area(s) of Application
Figure 6.7 SATO: Annual Revenues, FY 2018 – H1 2022 (JPY Billion)
Figure 6.8 SATO: Area(s) of Application
Figure 6.9 Invengo: Area(s) of Application
Figure 6.10 Intellhydro Technology: Area(s) of Application
Figure 6.11 RFiD Discovery: Area(s) of Application
Figure 6.12 ID Tech Solutions: Area(s) of Application
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2022
Figure 7.3 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 7.4 Patent Analysis: Distribution by CPC Symbols
Figure 7.5 Patent Analysis: Distribution by Type of Applicant
Figure 7.6 Patent Analysis: Distribution by Geography
Figure 7.7 Patent Analysis: Distribution by Emerging Focus Areas
Figure 7.8 Leading Industry Players: Distribution by Number of Patents
Figure 7.9 Patent Benchmarking: Distribution of Leading Industry Players by Patent Characteristics (CPC Symbols)
Figure 7.10 Patent Analysis: Distribution by Patent Age, 2015-2022
Figure 7.11 Patent Analysis: Categorizations based on Weighted Valuation Scores
Figure 7.12 Patent Analysis: Distribution by Patent Valuation
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend of Partnerships, 2018-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Most Active Players: Distribution by Number of Partnership Instances
Figure 8.5 Partnerships and Collaborations: Distribution by Local and International Agreements
Figure 8.6 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Figure 9.1 Red Ocean Strategy versus Blue Ocean Strategy
Figure 9.2 Blue Ocean Strategy: Strategy Canvas
Figure 9.3 Blue Ocean Strategy: Eliminate-Raise-Reduce-Create (ERRC) Grid
Figure 9.4 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map
Figure 9.5 Blue Ocean Strategy: Three Tiers of Noncustomers
Figure 9.6 Blue Ocean Strategy: Sequence of Blue Ocean Strategy
Figure 9.7 Blue Ocean Strategy: Buyer Utility Map
Figure 9.8 Blue Ocean Strategy: The Price Corridor of the Mass
Figure 10.1 Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035 (USD Billion)
Figure 10.2 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Technology, 2022-2035 (USD Million)
Figure 10.3 Smart Pharmaceutical and Healthcare Labels Market for RFID Labels, 2022-2035 (USD Million)
Figure 10.4 Smart Pharmaceutical and Healthcare Labels Market for NFC Labels, 2022-2035 (USD Million)
Figure 10.5 Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035 (USD Million)
Figure 10.6 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Packaging, 2022-2035 (USD Million)
Figure 10.7 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Primary Packaging, 2022-2035 (USD Million)
Figure 10.8 Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035 (USD Million)
Figure 10.9 Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035 (USD Million)
Figure 10.10 Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035 (USD Million)
Figure 10.11 Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035 (USD Million)
Figure 10.12 Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035 (USD Million)
Figure 10.13 Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035 (USD Million)
Figure 10.14 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Secondary Packaging, 2022-2035 (USD Million)
Figure 10.15 Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035 (USD Million)
Figure 10.16 Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035 (USD Million)
Figure 10.17 Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035 (USD Million)
Figure 10.18 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Geography, 2022-2035 (USD Million)
Figure 10.19 Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035 (USD Million)
Figure 10.20 Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035 (USD Million)
Figure 10.21 Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035 (USD Million)
Figure 10.22 Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035 (USD Million)
Figure 10.23 Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035 (USD Million)
Figure 11.1 SWOT Analysis: Harvey Ball Analysis
Figure 11.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 12.1 Concluding Remarks: Market Landscape
Figure 12.2 Concluding Remarks: Patent Analysis
Figure 12.3 Concluding Remarks: Partnerships and Collaborations
Figure 12.4 Concluding Remarks: Market Sizing and Opportunity Analysis (1/2)
Figure 12.5 Concluding Remarks: Market Sizing and Opportunity Analysis (2/2)
Table 4.1 Smart Pharmaceutical and Healthcare Label Providers: List of Companies
Table 4.2 Smart Pharmaceutical and Healthcare Label Providers: Information on Type of RFID Frequency Band
Table 4.3 Smart Pharmaceutical and Healthcare Label Providers: Information on Area(s) of Application
Table 5.1 Company Competitiveness: Benchmarking the Capabilities of Leading Players
Table 6.1 CCL Industries: Company Overview
Table 6.2 CCL Industries: Recent Developments and Future Outlook
Table 6.3 Schreiner: Company Overview
Table 6.4 Schreiner: Recent Developments and Future Outlook
Table 6.5 Datalogic: Company Overview
Table 6.6 Datalogic: Recent Developments and Future Outlook
Table 6.7 Tadbik: Company Overview
Table 6.8 SATO: Company Overview
Table 6.9 SATO: Recent Developments and Future Outlook
Table 6.10 Invengo: Company Overview
Table 6.11 Invengo: Recent Developments and Future Outlook
Table 6.12 Intellhydro Technology: Company Overview
Table 6.12 RFiD Discovery: Company Overview
Table 6.13 RFiD Discovery: Recent Developments and Future Outlook
Table 6.14 ID Tech Solutions: Company Overview
Table 7.1 Patent Analysis: Top CPC Sections
Table 7.2 Patent Analysis: Top CPC Symbols
Table 7.3 Patent Analysis: Top CPC Codes
Table 7.4 Patent Analysis: Summary of Benchmarking
Table 7.5 Patent Analysis: List of Leading Patents (by Highest Relative Valuation)
Table 8.1 Smart Pharmaceutical and Healthcare Labels: List of Partnerships and Collaborations
Table 10.1 Average Prices of Primary Packaging Containers and Secondary Packaging Containers
Table 13.1 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Year of Establishment
Table 13.2 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size
Table 13.3 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Location of Headquarters
Table 13.4 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Location of Headquarters
Table 13.5 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology
Table 13.6 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Type of Technology
Table 13.7 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of RFID Frequency Band
Table 13.8 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Area(s) of Application
Table 13.9 Smart Pharmaceutical and Healthcare Label Providers: Distribution Company Size and Area(s) of Application
Table 13.10 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology and Area(s) of Application
Table 13.11 CCL Industries: Annual Revenues, 2018 - 9M 2022 (CAD Billion)
Table 13.12 Datalogic: Annual Revenues, 2018 - 9M 2022 (EUR Billion)
Table 13.13 SATO: Annual Revenues, FY 2018 - H1 FY 2022 (JPY Billion)
Table 13.14 Patent Analysis: Distribution by Type of Patent
Table 13.15 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2022
Table 13.16 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 13.17 Patent Analysis: Distribution by Type of Applicant
Table 13.18 Patent Analysis: Distribution by Geography
Table 13.19 Leading Industry Players: Distribution by Number of Patents
Table 13.20 Patent Analysis: Distribution by Patent Age, 2015-2022
Table 13.21 Partnerships and Collaborations: Distribution by Cumulative Year-wise Trend of Partnerships, 2018-2022
Table 13.22 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.23 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.24 Most Active Players: Distribution by Number of Partnership Instances
Table 13.25 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 13.26 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Table 13.27 Global Smart Pharmaceutical and Healthcare Labels Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 13.28 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Technology, 2022, 2028 and 2035 (USD Million)
Table 13.29 Smart Pharmaceutical and Healthcare Labels Market for RFID Labels, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.30 Smart Pharmaceutical and Healthcare Labels Market for NFC Labels, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.31 Smart Pharmaceutical and Healthcare Labels Market for Other Labels, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.32 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Packaging, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.33 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Primary Packaging, 2022, 2028 and 2035 (USD Million)
Table 13.34 Smart Pharmaceutical and Healthcare Labels Market for Vials, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.35 Smart Pharmaceutical and Healthcare Labels Market for Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.36 Smart Pharmaceutical and Healthcare Labels Market for Cartridges, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.37 Smart Pharmaceutical and Healthcare Labels Market for Ampoules, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.38 Smart Pharmaceutical and Healthcare Labels Market for Bottles, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.39 Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.40 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Secondary Packaging, 2022, 2028 and 2035 (USD Million)
Table 13.41 Smart Pharmaceutical and Healthcare Labels Market for Boxes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.42 Smart Pharmaceutical and Healthcare Labels Market for Cartons, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.43 Smart Pharmaceutical and Healthcare Labels Market for Pouches, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.44 Smart Pharmaceutical and Healthcare Labels Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.45 Smart Pharmaceutical and Healthcare Labels Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.46 Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.47 Smart Pharmaceutical and Healthcare Labels Market in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 13.48 Smart Pharmaceutical and Healthcare Labels Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
The following companies and organizations have been mentioned in the report:
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES